Benzinga | Nov 3, 2021 05:49PM EDT

Theravance Biopharma Q3 Adj. EPS $(0.46) Beats $(0.55) Estimate, Sales $13.19M Miss $14.69M Estimate

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.55) by 16.36 percent. This is a 60.34 percent increase over losses of $(1.16) per share from the same period last year. The company reported quarterly sales of $13.19 million which missed the analyst consensus estimate of $14.69 million by 10.18 percent. This is a 27.73 percent decrease over sales of $18.26 million the same period last year.